{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:06:13Z","timestamp":1794492373080,"version":"4.9.1"},"reference-count":233,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T00:00:00Z","timestamp":1568764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41574-019-0254-y","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T06:02:37Z","timestamp":1568786557000},"page":"635-650","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":452,"title":["The heterogeneous pathogenesis of type 1 diabetes mellitus"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9973-2062","authenticated-orcid":false,"given":"Jorma","family":"Ilonen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Lempainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riitta","family":"Veijola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,18]]},"reference":[{"key":"254_CR1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrendo.2017.99","volume":"13","author":"R Buzzetti","year":"2017","unstructured":"Buzzetti, R., Zampetti, S. & Maddaloni, E. Adult-onset autoimmune diabetes: current knowledge and implications for management. Nature Rev. Endocrinol. 13, 674\u2013686 (2017).","journal-title":"Nature Rev. Endocrinol."},{"key":"254_CR2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(08)60765-5","volume":"371","author":"V Harjutsalo","year":"2008","unstructured":"Harjutsalo, V., Sj\u00f6berg, L. & Tuomilehto, J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 371, 1777\u20131782 (2008).","journal-title":"Lancet"},{"key":"254_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00592-016-0909-2","volume":"54","author":"M Songini","year":"2017","unstructured":"Songini, M., Mannu, C., Targhetta, C. & Bruno, G. Type 1 diabetes in Sardinia: facts and hypotheses in\u00a0the context of worldwide epidemiological data. Acta\u00a0Diabetol 54, 9\u201317 (2017).","journal-title":"Acta Diabetol."},{"key":"254_CR4","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00125-014-3225-9","volume":"57","author":"A Rawshani","year":"2014","unstructured":"Rawshani, A. et al. The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods. Diabetologia 57, 1375\u20131381 (2014).","journal-title":"Diabetologia"},{"key":"254_CR5","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/jama.297.24.2716","volume":"297","author":"D Dabelea","year":"2007","unstructured":"Dabelea, D. et al. Incidence of diabetes in youth in the United States. J. Am. Med. Assoc. 297, 2716\u20132724 (2007).","journal-title":"J. Am. Med. Assoc."},{"key":"254_CR6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00125-018-4763-3","volume":"62","author":"CC Patterson","year":"2018","unstructured":"Patterson, C. C. et al. Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a\u00a0multicentre prospective registration study. Diabetologia 62, 408\u2013417 (2018).","journal-title":"Diabetologia"},{"key":"254_CR7","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2337\/diabetes.51.12.3353","volume":"51","author":"EA Gale","year":"2002","unstructured":"Gale, E. A. The rise of childhood type 1 diabetes in the 20th century. Diabetes 51, 3353\u20133361 (2002).","journal-title":"Diabetes"},{"key":"254_CR8","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/diacare.23.10.1516","volume":"23","author":"M Karvonen","year":"2000","unstructured":"Karvonen, M. et al. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 23, 1516\u20131526 (2000).","journal-title":"Diabetes Care"},{"key":"254_CR9","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(13)62219-9","volume":"383","author":"T Tuomi","year":"2014","unstructured":"Tuomi, T. et al. The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383, 1084\u20131094 (2014).","journal-title":"Lancet"},{"key":"254_CR10","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","volume":"6","author":"NJ Thomas","year":"2018","unstructured":"Thomas, N. J. et al. Frequency and phenotype of type\u00a01 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol 6, 122\u2013129 (2018).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"254_CR11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.gde.2018.01.006","volume":"50","author":"CC Robertson","year":"2018","unstructured":"Robertson, C. C. & Rich, S. S. Genetics of type 1 diabetes. Curr. Opin. Genet. Dev. 50, 7\u201316 (2018).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"254_CR12","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","volume":"309","author":"AG Ziegler","year":"2013","unstructured":"Ziegler, A. G. et al. Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in\u00a0children. J. Am. Med. Assoc. 309, 2473\u20132479 (2013).","journal-title":"J. Am. Med. Assoc."},{"key":"254_CR13","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s001250051309","volume":"42","author":"P Onkamo","year":"1999","unstructured":"Onkamo, P., V\u00e4\u00e4n\u00e4nen, S., Karvonen, M. & Tuomilehto, J. Worldwide increase in incidence of type\u00a0I diabetes\u2014the analysis of the data on published incidence trends. Diabetologia 42, 1395\u20131403 (1999).","journal-title":"Diabetologia"},{"key":"254_CR14","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1016\/S0140-6736(16)30507-4","volume":"387","author":"M Rewers","year":"2016","unstructured":"Rewers, M. & Ludvigsson, J. Environmental risk factors for type 1 diabetes. Lancet 387, 2340\u20132348 (2016).","journal-title":"Lancet"},{"key":"254_CR15","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.2337\/db13-0300","volume":"62","author":"J Ilonen","year":"2013","unstructured":"Ilonen, J. et al. Patterns of \u03b2-cell autoantibody appearance and genetic associations during the first\u00a0years of life. Diabetes 62, 3636\u20133640 (2013).","journal-title":"Diabetes"},{"key":"254_CR16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jaut.2015.05.005","volume":"61","author":"J Lempainen","year":"2015","unstructured":"Lempainen, J. et al. Non-HLA gene effects on the disease process of type 1 diabetes: from HLA susceptibility to overt disease. J. Autoimmun. 61, 45\u201353 (2015).","journal-title":"J. Autoimmun."},{"key":"254_CR17","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1007\/s00125-015-3672-y","volume":"58","author":"EZ Giannopoulou","year":"2015","unstructured":"Giannopoulou, E. Z. et al. Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes. Diabetologia 58, 2317\u20132323 (2015).","journal-title":"Diabetologia"},{"key":"254_CR18","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2337\/dc17-0238","volume":"40","author":"JP Krischer","year":"2017","unstructured":"Krischer, J. P. et al. Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the TEDDY study. Diabetes Care 40, 1194\u20131202 (2017).","journal-title":"Diabetes Care"},{"key":"254_CR19","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/db07-1331","volume":"57","author":"H Erlich","year":"2008","unstructured":"Erlich, H. et al. HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 57, 1084\u20131092 (2008).","journal-title":"Diabetes"},{"key":"254_CR20","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1399-0039.2007.00867.x","volume":"70","author":"G Thomson","year":"2007","unstructured":"Thomson, G. et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 70, 110\u2013127 (2007).","journal-title":"Tissue Antigens"},{"key":"254_CR21","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.4049\/jimmunol.141.9.3123","volume":"141","author":"WW Kwok","year":"1988","unstructured":"Kwok, W. W. et al. HLA-DQ molecules form alpha-beta heterodimers of mixed allotype. J. Immunol. 141, 3123\u20133127 (1988).","journal-title":"J. Immunol."},{"key":"254_CR22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/338587a0","volume":"338","author":"JA Todd","year":"1989","unstructured":"Todd, J. A. et al. Identification of susceptibility loci for insulin-dependent diabetes mellitus by trans-racial gene mapping. Nature 338, 587\u2013589 (1989).","journal-title":"Nature"},{"key":"254_CR23","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/ng.3353","volume":"47","author":"X Hu","year":"2015","unstructured":"Hu, X. et al. Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nat Genet. 47, 898\u2013905 (2015).","journal-title":"Nature Genet."},{"key":"254_CR24","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/diab.39.10.1153","volume":"39","author":"GT Nepom","year":"1990","unstructured":"Nepom, G. T. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes 39, 1153\u20131157 (1990).","journal-title":"Diabetes"},{"key":"254_CR25","doi-asserted-by":"crossref","DOI":"10.1186\/s13059-017-1207-1","volume":"18","author":"V Matzaraki","year":"2017","unstructured":"Matzaraki, V., Kumar, V., Wijmenga, C. & Zhernakova, A. The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biol. 18, 76 (2017).","journal-title":"Genome Biol."},{"key":"254_CR26","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM200009073431006","volume":"343","author":"J Klein","year":"2000","unstructured":"Klein, J. & Sato, A. The HLA system. First of two parts. N. Engl. J. Med. 343, 702\u2013709 (2000).","journal-title":"N. Engl. J. Med."},{"key":"254_CR27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1568-9972(02)00062-9","volume":"1","author":"L Guilherme","year":"2002","unstructured":"Guilherme, L. & Kalil, J. Rheumatic fever: the T cell response leading to autoimmune aggression in the heart. Autoimmun Rev. 1, 261\u2013266 (2002).","journal-title":"Autoimmun. Rev."},{"key":"254_CR28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/pedi.12327","volume":"17","author":"J Ilonen","year":"2016","unstructured":"Ilonen, J. et al. Genetic susceptibility to type 1 diabetes in childhood \u2014 estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity. Pediatr. Diabetes 17 (Suppl. 22), 8\u201316 (2016).","journal-title":"Pediatr. Diabetes"},{"key":"254_CR29","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","volume":"155","author":"A Willcox","year":"2009","unstructured":"Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K. & Morgan, N. G. Analysis of islet inflammation in human type 1 diabetes. Clin. Exp. Immunol. 155, 173\u2013181 (2009).","journal-title":"Clin. Exp. Immunol."},{"key":"254_CR30","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.2337\/diab.46.11.1888","volume":"46","author":"S Nejentsev","year":"1997","unstructured":"Nejentsev, S. et al. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes 46, 1888\u20131892 (1997).","journal-title":"Diabetes"},{"key":"254_CR31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/nature06406","volume":"450","author":"S Nejentsev","year":"2007","unstructured":"Nejentsev, S. et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 450, 887\u2013892 (2007).","journal-title":"Nature"},{"key":"254_CR32","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/sj.gene.6364328","volume":"7","author":"JR Bilbao","year":"2006","unstructured":"Bilbao, J. R. et al. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Genes Immun. 7, 550\u2013554 (2006).","journal-title":"Genes Immun."},{"key":"254_CR33","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.2337\/db10-0699","volume":"59","author":"JA Noble","year":"2010","unstructured":"Noble, J. A. et al. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes 59, 2972\u20132979 (2010).","journal-title":"Diabetes"},{"key":"254_CR34","first-page":"1134","volume":"59","author":"JA Noble","year":"1996","unstructured":"Noble, J. A. et al. The role of HLA class II genes in insulin-dependent diabetes mellitus: molecular analysis of 180 Caucasian, multiplex families. Am. J. Hum. Genet. 59, 1134\u20131148 (1996).","journal-title":"Am. J. Hum. Genet."},{"key":"254_CR35","first-page":"215","volume":"89","author":"ML Mikk","year":"2017","unstructured":"Mikk, M. L. et al. The association of the HLA-A*24:02, B*39:01 and B*39:06 alleles with\u00a0type 1 diabetes is restricted to specific HLA-DR\/DQ haplotypes in Finns. HLA 89, 215\u2013224 (2017).","journal-title":"HL\u200aA"},{"key":"254_CR36","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1007\/s00125-013-2951-8","volume":"56","author":"E Mbunwe","year":"2013","unstructured":"Mbunwe, E. et al. In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions. Diabetologia 56, 1964\u20131970 (2013).","journal-title":"Diabetologia"},{"key":"254_CR37","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1034\/j.1399-0039.2003.00013.x","volume":"61","author":"BD Tait","year":"2003","unstructured":"Tait, B. D. et al. HLA genes associated with autoimmunity and progression to disease in type 1 diabetes. Tissue Antigens 61, 146\u2013153 (2003).","journal-title":"Tissue Antigens"},{"key":"254_CR38","doi-asserted-by":"crossref","first-page":"a007732","DOI":"10.1101\/cshperspect.a007732","volume":"2","author":"JA Noble","year":"2012","unstructured":"Noble, J. A. & Erlich, H. A. Genetics of type 1 diabetes. Cold Spring Harb. Perspect. Med. 2, a007732 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"254_CR39","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ng0397-293","volume":"15","author":"A Pugliese","year":"1997","unstructured":"Pugliese, A. et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nature Genet. 15, 293\u2013297 (1997).","journal-title":"Nature Genet."},{"key":"254_CR40","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1323","volume":"36","author":"N Bottini","year":"2004","unstructured":"Bottini, N. et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nature Genet. 36, 337\u2013338 (2004).","journal-title":"Nature Genet."},{"key":"254_CR41","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","volume":"387","author":"F Pociot","year":"2016","unstructured":"Pociot, F. & Lernmark, \u00c5. Genetic risk factors for type\u00a01 diabetes. Lancet 387, 2331\u20132339 (2016).","journal-title":"Lancet"},{"key":"254_CR42","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/ng2102","volume":"39","author":"CE Lowe","year":"2007","unstructured":"Lowe, C. E. et al. Large-scale genetic fine mapping and\u00a0genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat. Genet. 39, 1074\u20131082 (2007).","journal-title":"Nat. Genet."},{"key":"254_CR43","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1038\/s41431-018-0123-5","volume":"26","author":"Y Ge","year":"2018","unstructured":"Ge, Y. & Concannon, P. Molecular-genetic characterization of common, noncoding UBASH3A variants associated with type 1 diabetes. Eur. J. Hum. Genet. 26, 1060\u20131064 (2018).","journal-title":"Eur. J. Hum. Genet."},{"key":"254_CR44","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.2337\/diabetes.53.7.1884","volume":"53","author":"BJ Barratt","year":"2004","unstructured":"Barratt, B. J. et al. Remapping the insulin gene\/IDDM2 locus in type 1 diabetes. Diabetes 53, 1884\u20131889 (2004).","journal-title":"Diabetes"},{"key":"254_CR45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ygeno.2013.03.003","volume":"101","author":"KJ Brookes","year":"2013","unstructured":"Brookes, K. J. The VNTR in complex disorders: the forgotten polymorphisms? A functional way forward? Genomics 101, 273\u2013281 (2013).","journal-title":"Genomics"},{"key":"254_CR46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng0397-289","volume":"15","author":"P Vafiadis","year":"1997","unstructured":"Vafiadis, P. et al. Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus. Nat. Genet. 15, 289\u2013292 (1997).","journal-title":"Nat. Genet."},{"key":"254_CR47","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/db10-0076","volume":"59","author":"F Pociot","year":"2010","unstructured":"Pociot, F. et al. Genetics of type 1 diabetes: what's next? Diabetes 59, 1561\u20131571 (2010).","journal-title":"Diabetes"},{"key":"254_CR48","doi-asserted-by":"crossref","first-page":"pii:E1106","DOI":"10.3390\/ijms17071106","volume":"17","author":"A Fierabracci","year":"2016","unstructured":"Fierabracci, A. Type 1 diabetes in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome (APECED): a \u201crare\u201d manifestation in a \u201crare\u201d disease. Int. J. Mol. Sci. 17, E1106 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"254_CR49","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fimmu.2012.00211","volume":"3","author":"F Barzaghi","year":"2012","unstructured":"Barzaghi, F., Passerini, L. & Bacchetta, R. Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front. Immunol. 3, 211 (2012).","journal-title":"Front. Immunol."},{"key":"254_CR50","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00125-017-4377-1","volume":"60","author":"CM Hull","year":"2017","unstructured":"Hull, C. M., Peakman, M. & Tree, T. I. M. Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it? Diabetologia 60, 1839\u20131850 (2017).","journal-title":"Diabetologia"},{"key":"254_CR51","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev-immunol-032713-120249","volume":"32","author":"N Bottini","year":"2014","unstructured":"Bottini, N. & Peterson, E. J. Tyrosine phosphatase PTPN22: multifunctional regulator of immune signaling, development, and disease. Annu. Rev. Immunol. 32, 83\u2013119 (2014).","journal-title":"Annu. Rev. Immunol."},{"key":"254_CR52","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1126\/science.1167728","volume":"324","author":"S Nejentsev","year":"2009","unstructured":"Nejentsev, S., Walker, N., Riches, D., Egholm, M. &\u00a0Todd, J. A. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 324, 387\u2013389 (2009).","journal-title":"Science"},{"key":"254_CR53","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.2337\/db15-0362","volume":"64","author":"L Marroqui","year":"2015","unstructured":"Marroqui, L. et al. TYK2, a candidate gene for type 1 diabetes, modulates apoptosis and the innate immune response in human pancreatic \u03b2-cells. Diabetes 64, 3808\u20133817 (2015).","journal-title":"Diabetes"},{"key":"254_CR54","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.4049\/jimmunol.1502056","volume":"196","author":"R Ram","year":"2016","unstructured":"Ram, R. et al. Systematic evaluation of genes and genetic variants associated with type 1 diabetes susceptibility. J. Immunol. 196, 3043\u20133053 (2016).","journal-title":"J. Immunol."},{"key":"254_CR55","doi-asserted-by":"crossref","first-page":"E167","DOI":"10.3390\/genes8060167","volume":"8","author":"R Ram","year":"2017","unstructured":"Ram, R. & Morahan, G. Effects of type 1 diabetes risk alleles on immune cell gene expression. Genes 8, E167 (2017).","journal-title":"Genes (Basel)"},{"key":"254_CR56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11892-016-0738-2","volume":"16","author":"V Lampasona","year":"2016","unstructured":"Lampasona, V. & Liberati, D. Islet autoantibodies. Curr. Diab. Rep. 16, 53 (2016).","journal-title":"Curr. Diab. Rep."},{"key":"254_CR57","first-page":"a007781","volume":"2","author":"BO Roep","year":"2012","unstructured":"Roep, B. O. & Peakman, M. Antigen targets of type 1 diabetes autoimmunity. Cold Spring Harb. Perspect. Med. 2, a007781 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"254_CR58","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.2337\/db15-1058","volume":"65","author":"KA McLaughlin","year":"2016","unstructured":"McLaughlin, K. A. et al. Identification of tetraspanin-7 as a target of autoantibodies in type 1 diabetes. Diabetes 65, 1690\u20131698 (2016).","journal-title":"Diabetes"},{"key":"254_CR59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2017.09.012","volume":"86","author":"Q Ling","year":"2018","unstructured":"Ling, Q. et al. Risk of beta-cell autoimmunity presence for progression to type 1 diabetes: a systematic review and meta-analysis. J. Autoimmun. 86, 9\u201318 (2018).","journal-title":"J. Autoimmun."},{"key":"254_CR60","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/MED.0000000000000267","volume":"23","author":"JM Sosenko","year":"2016","unstructured":"Sosenko, J. M. Staging the progression to type 1 diabetes with prediagnostic markers. Curr. Opin. Endocrinol. Diabetes Obes. 23, 297\u2013305 (2016).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"254_CR61","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","volume":"38","author":"RA Insel","year":"2015","unstructured":"Insel, R. A. et al. Staging presymptomatic type 1 diabetes: a Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38, 1964\u20131974 (2015).","journal-title":"Diabetes Care"},{"key":"254_CR62","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00125-016-4147-5","volume":"60","author":"M Knip","year":"2017","unstructured":"Knip, M., Selvenius, J., Siljander, H. & Veijola, R. Reclassification of asymptomatic beta cell autoimmunity: a critical perspective. Diabetologia 60, 39\u201342 (2017).","journal-title":"Diabetologia"},{"key":"254_CR63","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.2337\/dc16-0181","volume":"39","author":"K Vehik","year":"2016","unstructured":"Vehik, K. et al. Reversion of \u03b2-cell autoimmunity changes risk of type 1 diabetes: TEDDY study. Diabetes Care 39, 1535\u20131542 (2016).","journal-title":"Diabetes Care"},{"key":"254_CR64","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1046\/j.1365-2249.2001.01676.x","volume":"126","author":"AM H\u00e4m\u00e4l\u00e4inen","year":"2001","unstructured":"H\u00e4m\u00e4l\u00e4inen, A. M. et al. Disease-associated autoantibodies during pregnancy and at birth in families affected by type 1 diabetes. Clin. Exp. Immunol. 126, 230\u2013235 (2001).","journal-title":"Clin. Exp. Immunol."},{"key":"254_CR65","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1530\/EJE-10-0792","volume":"164","author":"S Eising","year":"2011","unstructured":"Eising, S. et al. Danish children born with glutamic acid decarboxylase-65 and islet antigen-2 autoantibodies at birth had an increased risk to develop type 1 diabetes. Eur. J. Endocrinol. 164, 247\u2013252 (2011).","journal-title":"Eur. J. Endocrinol."},{"key":"254_CR66","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00125-014-3394-6","volume":"58","author":"M Lundgren","year":"2015","unstructured":"Lundgren, M., Lynch, K., Larsson, C. & Elding Larsson, H., Diabetes Prediction in Sk\u00e5ne study group. Cord blood insulinoma-associated protein 2 autoantibodies are associated with increased risk of type\u00a01 diabetes in the population-based Diabetes Prediction in Sk\u00e5ne study. Diabetologia 58, 75\u201378 (2015).","journal-title":"Diabetologia"},{"key":"254_CR67","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2337\/db05-1296","volume":"55","author":"V Harjutsalo","year":"2006","unstructured":"Harjutsalo, V., Reunanen, A. & Tuomilehto, J. Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring. Diabetes 55, 1517\u20131524 (2006).","journal-title":"Diabetes"},{"key":"254_CR68","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11892-014-0543-8","volume":"14","author":"RM Hinman","year":"2014","unstructured":"Hinman, R. M. & Cambier, J. C. Role of B lymphocytes in the pathogenesis of type 1 diabetes. Curr. Diab. Rep. 14, 543 (2014).","journal-title":"Curr. Diab. Rep."},{"key":"254_CR69","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/eji.201141613","volume":"42","author":"N van Montfoort","year":"2012","unstructured":"van Montfoort, N. et al. Circulating specific antibodies enhance systemic cross-priming by delivery of complexed antigen to dendritic cells in vivo. Eur J. Immunol. 42, 598\u2013606 (2012).","journal-title":"Eur J. Immunol."},{"key":"254_CR70","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/dc13-0626","volume":"37","author":"MD Pescovitz","year":"2014","unstructured":"Pescovitz, M. D. et al. B-lymphocyte depletion with rituximab and \u03b2-cell function: two-year results. Diabetes Care 37, 453\u2013459 (2014).","journal-title":"Diabetes Care"},{"key":"254_CR71","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2337\/diab.14.10.619","volume":"14","author":"W Gepts","year":"1965","unstructured":"Gepts, W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14, 619\u2013633 (1965).","journal-title":"Diabetes"},{"key":"254_CR72","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00125-018-4731-y","volume":"61","author":"NG Morgan","year":"2018","unstructured":"Morgan, N. G. & Richardson, S. J. Fifty years of pancreatic islet pathology in human type 1 diabetes: insights gained and progress made. Diabetologia 61, 2499\u20132506 (2018).","journal-title":"Diabetologia"},{"key":"254_CR73","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s00125-015-3820-4","volume":"59","author":"L Krogvold","year":"2016","unstructured":"Krogvold, L. et al. Insulitis and characterisation of infiltrating T cells in surgical pancreatic tail resections from patients at onset of type 1 diabetes. Diabetologia 59, 492\u2013501 (2016).","journal-title":"Diabetologia"},{"key":"254_CR74","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/BF00452061","volume":"29","author":"AK Foulis","year":"1986","unstructured":"Foulis, A. K., Liddle, C. N., Farquharson, M. A., Richmond, J. A. & Weir, R. S. The histopathology of the pancreas in type 1 (insulin-dependent) diabetes mellitus: a 25-year review of deaths in patients under 20 years of age in the United Kingdom. Diabetologia 29, 267\u2013274 (1986).","journal-title":"Diabetologia"},{"key":"254_CR75","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2337\/db15-0779","volume":"65","author":"M Campbell-Thompson","year":"2016","unstructured":"Campbell-Thompson, M. et al. Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes. Diabetes 65, 719\u2013731 (2016).","journal-title":"Diabetes"},{"key":"254_CR76","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/db15-1615","volume":"65","author":"P Leete","year":"2016","unstructured":"Leete, P. et al. Differential insulitic profiles determine the extent of \u03b2-cell destruction and the age at onset of type 1 diabetes. Diabetes 65, 1362\u20131369 (2016).","journal-title":"Diabetes"},{"key":"254_CR77","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1007\/s00125-016-4067-4","volume":"59","author":"SJ Richardson","year":"2016","unstructured":"Richardson, S. J. et al. Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes. Diabetologia 59, 2448\u20132458 (2016).","journal-title":"Diabetologia"},{"key":"254_CR78","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/dmrr.1236","volume":"27","author":"A Imagawa","year":"2011","unstructured":"Imagawa, A. & Hanafusa, T. Fulminant type 1 diabetes\u2014an important subtype in East Asia. Diabetes Metab. Res. Rev. 27, 959\u2013964 (2011).","journal-title":"Diabetes Metab. Res. Rev."},{"key":"254_CR79","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diabres.2017.07.036","volume":"133","author":"T Iijima","year":"2017","unstructured":"Iijima, T. et al. Circulating CD4+PD-1+ and CD8+PD-1+ T cells are profoundly decreased at the onset of fulminant type 1 diabetes and are restored by treatment, contrasting with CD4+CD25+FoxP3+ regulatory T cells. Diabetes Res. Clin. Pract. 133, 10\u201312 (2017).","journal-title":"Diabetes Res. Clin. Pract."},{"key":"254_CR80","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.2337\/db09-0249","volume":"58","author":"KC Herold","year":"2009","unstructured":"Herold, K. C. et al. Validity and reproducibility of measurement of islet autoreactivity by T-cell assays in subjects with early type 1 diabetes. Diabetes 58, 2588\u20132595 (2009).","journal-title":"Diabetes"},{"key":"254_CR81","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jaut.2005.08.007","volume":"25","author":"NA Danke","year":"2005","unstructured":"Danke, N. A., Yang, J., Greenbaum, C. & Kwok, W. W. Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects. J. Autoimmun. 25, 303\u2013311 (2005).","journal-title":"J. Autoimmun."},{"key":"254_CR82","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/db14-0332","volume":"64","author":"A Skowera","year":"2015","unstructured":"Skowera, A. et al. \u03b2-cell-specific CD8 T cell phenotype in type 1 diabetes reflects chronic autoantigen exposure. Diabetes 64, 916\u2013925 (2015).","journal-title":"Diabetes"},{"key":"254_CR83","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11892-017-0915-y","volume":"17","author":"SC Kent","year":"2017","unstructured":"Kent, S. C., Mannering, S. I., Michels, A. W. & Babon,\u00a0J. A. B. Deciphering the pathogenesis of human type 1 diabetes (T1D) by interrogating T cells from the \u201cscene of the crime\u201d. Curr. Diab. Rep. 17, 95 (2017).","journal-title":"Curr. Diab. Rep."},{"key":"254_CR84","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20111187","volume":"209","author":"KT Coppieters","year":"2012","unstructured":"Coppieters, K. T. et al. Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent\u00a0onset and long-term type 1 diabetes patients. J. Exp. Med. 209, 51\u201360 (2012).","journal-title":"J. Exp. Med."},{"key":"254_CR85","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db14-0858","volume":"64","author":"V Pathiraja","year":"2015","unstructured":"Pathiraja, V. et al. Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes. Diabetes 64, 172\u2013182 (2015).","journal-title":"Diabetes"},{"key":"254_CR86","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/nm.4203","volume":"22","author":"JA Babon","year":"2016","unstructured":"Babon, J. A. et al. Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes. Nature Med. 22, 1482\u20131487 (2016).","journal-title":"Nature Med."},{"key":"254_CR87","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/imm.12640","volume":"149","author":"H Nguyen","year":"2016","unstructured":"Nguyen, H. & James, E. A. Immune recognition of citrullinated epitopes. Immunology 149, 131\u2013138 (2016).","journal-title":"Immunology"},{"key":"254_CR88","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00251-017-0985-7","volume":"69","author":"LM Sollid","year":"2017","unstructured":"Sollid, L. M. The roles of MHC class II genes and post-translational modification in celiac disease. Immunogenetics 69, 605\u2013616 (2017).","journal-title":"Immunogenetics"},{"key":"254_CR89","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2337\/dbi17-0030","volume":"67","author":"EA James","year":"2018","unstructured":"James, E. A., Pietropaolo, M. & Mamula, M. J. Immune recognition of \u03b2-cells: neoepitopes as key players in the loss of tolerance. Diabetes 67, 1035\u20131042 (2018).","journal-title":"Diabetes"},{"key":"254_CR90","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.aad2791","volume":"351","author":"T Delong","year":"2016","unstructured":"Delong, T. et al. Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion. Science 351, 711\u2013714 (2016).","journal-title":"Science"},{"key":"254_CR91","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/cei.12892","volume":"187","author":"M Radenkovic","year":"2017","unstructured":"Radenkovic, M. et al. Characterization of resident lymphocytes in human pancreatic islets. Clin. Exp. Immunol. 187, 418\u2013427 (2017).","journal-title":"Clin. Exp. Immunol."},{"key":"254_CR92","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ajpath.2016.11.002","volume":"187","author":"E Kuric","year":"2017","unstructured":"Kuric, E. et al. Demonstration of tissue resident memory CD8 T cells in insulitic lesions in adult patients with recent-onset type 1 diabetes. Am. J. Pathol. 187, 581\u2013588 (2017).","journal-title":"Am. J. Pathol."},{"key":"254_CR93","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.2337\/db14-0549","volume":"63","author":"T Rodriguez-Calvo","year":"2014","unstructured":"Rodriguez-Calvo, T., Ekwall, O., Amirian, N., Zapardiel-Gonzalo, J. & von Herrath, M. G. Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 63, 3880\u20133890 (2014).","journal-title":"Diabetes"},{"key":"254_CR94","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/pedi.12592","volume":"19","author":"A Kondrashova","year":"2018","unstructured":"Kondrashova, A. et al. Exocrine pancreas function decreases during the progression of the beta-cell damaging process in young prediabetic children. Pediatr. Diabetes 19, 398\u2013402 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"254_CR95","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/MED.0b013e32835edb89","volume":"20","author":"O Skog","year":"2013","unstructured":"Skog, O., Korsgren, S., Melhus, A. & Korsgren, O. Revisiting the notion of type 1 diabetes being a T-cell-mediated autoimmune disease. Curr. Opin. Endocrinol. Diabetes Obes. 20, 118\u2013123 (2013).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"254_CR96","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/dom.13144","volume":"20","author":"O Skog","year":"2018","unstructured":"Skog, O. & Korsgren, O. Aetiology of type 1 diabetes: physiological growth in children affects disease progression. Diabetes Obes. Metab. 20, 775\u2013785 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"254_CR97","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s00125-003-1045-4","volume":"46","author":"R Hermann","year":"2003","unstructured":"Hermann, R. et al. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes\u2014indication of an increased environmental pressure? Diabetologia 46, 420\u2013425 (2003).","journal-title":"Diabetologia"},{"key":"254_CR98","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0140-6736(04)17357-1","volume":"364","author":"KM Gillespie","year":"2004","unstructured":"Gillespie, K. M. et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364, 1699\u20131700 (2004).","journal-title":"Lancet"},{"key":"254_CR99","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.2337\/dc07-2210","volume":"31","author":"K Vehik","year":"2008","unstructured":"Vehik, K. et al. Trends in high-risk HLA susceptibility genes among Colorado youth with type 1 diabetes. Diabetes Care 31, 1392\u20131396 (2008).","journal-title":"Diabetes Care"},{"key":"254_CR100","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.2337\/dc08-0239","volume":"31","author":"S Fourlanos","year":"2008","unstructured":"Fourlanos, S. et al. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31, 1546\u20131549 (2008).","journal-title":"Diabetes Care"},{"key":"254_CR101","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1651-2227.2011.02410.x","volume":"101","author":"U S\u00f6derstr\u00f6m","year":"2012","unstructured":"S\u00f6derstr\u00f6m, U., Aman, J. & Hjern, A. Being born in Sweden increases the risk for type 1 diabetes \u2014 a study of migration of children to Sweden as a natural experiment. Acta Paediatr. 101, 73\u201377 (2012).","journal-title":"Acta Paediatr."},{"key":"254_CR102","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1399-5448.2011.00783.x","volume":"13","author":"T Oilinki","year":"2012","unstructured":"Oilinki, T., Otonkoski, T., Ilonen, J., Knip, M. & Miettinen, P. J. Prevalence and characteristics of diabetes among Somali children and adolescents living in Helsinki, Finland. Pediatr. Diabetes 13, 176\u2013180 (2012).","journal-title":"Pediatr. Diabetes"},{"key":"254_CR103","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1007\/s00125-017-4399-8","volume":"60","author":"A Peled","year":"2017","unstructured":"Peled, A. et al. Immigration to Israel during childhood is associated with diabetes at adolescence: a study of 2.7 million adolescents. Diabetologia 60, 2226\u20132230 (2017).","journal-title":"Diabetologia"},{"key":"254_CR104","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003418","volume":"3","author":"HI Hussen","year":"2013","unstructured":"Hussen, H. I., Persson, M. & Moradi, T. The trends and the risk of type 1 diabetes over the past 40 years: an analysis by birth cohorts and by parental migration background in Sweden. BMJ Open 3, e003418 (2013).","journal-title":"BMJ Open"},{"key":"254_CR105","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2337\/dc14-2348","volume":"38","author":"HI Hussen","year":"2015","unstructured":"Hussen, H. I., Moradi, T. & Persson, M. The risk of type 1 diabetes among offspring of immigrant mothers in relation to the duration of residency in Sweden. Diabetes Care 38, 934\u2013936 (2015).","journal-title":"Diabetes Care"},{"key":"254_CR106","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0140-6736(96)04241-9","volume":"349","author":"S Muntoni","year":"1997","unstructured":"Muntoni, S. et al. Incidence of insulin-dependent diabetes mellitus among Sardinian-heritage children born in Lazio region, Italy. Lancet 349, 160\u2013162 (1997).","journal-title":"Lancet"},{"key":"254_CR107","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1210\/jc.2009-1818","volume":"95","author":"J Ji","year":"2010","unstructured":"Ji, J., Hemminki, K., Sundquist, J. & Sundquist, K. Ethnic differences in incidence of type 1 diabetes among second-generation immigrants and adoptees from abroad. J. Clin. Endocrinol. Metab. 95, 847\u2013850 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"254_CR108","first-page":"149","volume":"14","author":"ME Craig","year":"2013","unstructured":"Craig, M. E., Nair, S., Stein, H. & Rawlinson, W. D. Viruses and type 1 diabetes: a new look at an old story. Pediatr. Diabetes 14, 149\u2013158 (2013).","journal-title":"Pediatr. Diabetes"},{"key":"254_CR109","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s00125-005-0076-4","volume":"49","author":"G Dahlquist","year":"2006","unstructured":"Dahlquist, G. Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis. Diabetologia 49, 20\u201324 (2006).","journal-title":"Diabetologia"},{"key":"254_CR110","first-page":"397","volume":"12","author":"Z Laron","year":"1999","unstructured":"Laron, Z., Shamis, I., Nitzan-Kaluski, D. & Ashkenazi, I. Month of birth and subsequent development of type I diabetes (IDDM). J. Pediatr. Endocrinol. Metab. 12, 397\u2013402 (1999).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"254_CR111","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1515\/JPEM.2001.14.6.781","volume":"14","author":"M Songini","year":"2001","unstructured":"Songini, M., Casu, A., Ashkenazi, I. & Laron, Z. Seasonality of birth in children (0-14 years) and young adults (0-29 years) with type 1 diabetes mellitus in Sardinia differs from that in the general population. the Sardinian Collaborative Group for Epidemiology of IDDM. J. Pediatr. Endocrinol. Metab. 14, 781\u2013783 (2001).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"254_CR112","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.2337\/dc09-0891","volume":"32","author":"HS Kahn","year":"2009","unstructured":"Kahn, H. S. et al. Association of type 1 diabetes with month of birth among U.S. youth: the SEARCH for Diabetes in Youth study. Diabetes Care 32, 2010\u20132015 (2009).","journal-title":"Diabetes Care"},{"key":"254_CR113","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00431-002-0941-9","volume":"161","author":"O Kordonouri","year":"2002","unstructured":"Kordonouri, O., Shuga, N., Lewy, H., Ashkenazi, I. & Laron, Z. Seasonality of month of birth of children and adolescents with type 1 diabetes mellitus in Berlin differs from the general population. Eur. J. Pediatr. 161, 291\u2013292 (2002).","journal-title":"Eur. J. Pediatr."},{"key":"254_CR114","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00125-006-0456-4","volume":"50","author":"AM Vaiserman","year":"2007","unstructured":"Vaiserman, A. M. et al. Seasonality of birth in children and young adults (0-29 years) with type 1 diabetes in Ukraine. Diabetologia 50, 32\u201335 (2007).","journal-title":"Diabetologia"},{"key":"254_CR115","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fimmu.2014.00446","volume":"5","author":"S Niewiesk","year":"2014","unstructured":"Niewiesk, S. Maternal antibodies: clinical significance, mechanism of interference with immune responses, and possible vaccination strategies. Front. Immunol. 5, 446 (2014).","journal-title":"Front. Immunol."},{"key":"254_CR116","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM197905243002102","volume":"300","author":"JW Yoon","year":"1979","unstructured":"Yoon, J. W., Austin, M., Onodera, T. & Notkins, A. L. Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Engl. J. Med. 300, 1173\u20131179 (1979).","journal-title":"N. Engl. J. Med."},{"key":"254_CR117","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00125-003-1297-z","volume":"47","author":"P Ylipaasto","year":"2004","unstructured":"Ylipaasto, P. et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47, 225\u2013239 (2004).","journal-title":"Diabetologia"},{"key":"254_CR118","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.2337\/db14-1370","volume":"64","author":"L Krogvold","year":"2015","unstructured":"Krogvold, L. et al. Detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 64, 1682\u20131687 (2015).","journal-title":"Diabetes"},{"key":"254_CR119","doi-asserted-by":"crossref","first-page":"12620","DOI":"10.18632\/oncotarget.14896","volume":"8","author":"N Busse","year":"2017","unstructured":"Busse, N. et al. Detection and localization of viral infection in the pancreas of patients with type 1 diabetes using short fluorescently-labelled oligonucleotide probes. Oncotarget 8, 12620\u201312636 (2017).","journal-title":"Oncotarget"},{"key":"254_CR120","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00125-009-1276-0","volume":"52","author":"SJ Richardson","year":"2009","unstructured":"Richardson, S. J., Willcox, A., Bone, A. J., Foulis, A. K. & Morgan, N. G. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52, 1143\u20131151 (2009).","journal-title":"Diabetologia"},{"key":"254_CR121","doi-asserted-by":"crossref","first-page":"6067","DOI":"10.3390\/v7112924","volume":"7","author":"EK Alidjinou","year":"2015","unstructured":"Alidjinou, E. K., San\u00e9, F., Trauet, J., Copin, M. C. & Hober, D. Coxsackievirus B4 can infect human peripheral blood-derived macrophages. Viruses 7, 6067\u20136079 (2015).","journal-title":"Viruses"},{"key":"254_CR122","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1464-5491.2004.01182.x","volume":"21","author":"J Green","year":"2004","unstructured":"Green, J., Casabonne, D. & Newton, R. Coxsackie B virus serology and type 1 diabetes mellitus: a systematic review of published case-control studies. Diabet Med. 21, 507\u2013514 (2004).","journal-title":"Diabet Med."},{"key":"254_CR123","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1128\/JCM.41.2.841-844.2003","volume":"41","author":"ME Craig","year":"2003","unstructured":"Craig, M. E., Robertson, P., Howard, N. J., Silink, M. &\u00a0Rawlinson, W. D. Diagnosis of enterovirus infection by genus-specific PCR and enzyme-linked immunosorbent assays. J. Clin. Microbiol. 41, 841\u2013844 (2003).","journal-title":"J. Clin. Microbiol."},{"key":"254_CR124","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1046\/j.1464-5491.1999.00098.x","volume":"16","author":"C Nairn","year":"1999","unstructured":"Nairn, C., Galbraith, D. N., Taylor, K. W. & Clements,\u00a0G. B. Enterovirus variants in the serum of children at the onset of type 1 diabetes mellitus. Diabet Med. 16, 509\u2013513 (1999).","journal-title":"Diabet Med."},{"key":"254_CR125","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/pedi.12673","volume":"19","author":"G Federico","year":"2018","unstructured":"Federico, G. et al. Vitamin D status, enterovirus infection, and type 1 diabetes in Italian children\/adolescents. Pediatr. Diabetes 19, 923\u2013929 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"254_CR126","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/infdis\/175.3.554","volume":"175","author":"M Hiltunen","year":"1997","unstructured":"Hiltunen, M. et al. Islet cell antibody seroconversion in children is temporally associated with enterovirus infections. Childhood Diabetes in Finland (DiMe) study group. J. Infect. Dis. 175, 554\u2013560 (1997).","journal-title":"J. Infect. Dis."},{"key":"254_CR127","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2337\/diabetes.49.8.1314","volume":"49","author":"M L\u00f6nnrot","year":"2000","unstructured":"L\u00f6nnrot, M. et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention study. Diabetes 49, 1314\u20131318 (2000).","journal-title":"Diabetes"},{"key":"254_CR128","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1096-9071(200006)61:2<214::AID-JMV7>3.0.CO;2-9","volume":"61","author":"M L\u00f6nnrot","year":"2000","unstructured":"L\u00f6nnrot, M. et al. Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) study group. J. Med. Virol. 61, 214\u2013220 (2000).","journal-title":"J. Med. Virol."},{"key":"254_CR129","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/jmv.10260","volume":"69","author":"K Salminen","year":"2003","unstructured":"Salminen, K. et al. Enterovirus infections are associated with the induction of beta-cell autoimmunity in a prospective birth cohort study. J. Med. Virol. 69, 91\u201398 (2003).","journal-title":"J. Med. Virol."},{"key":"254_CR130","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.2337\/db10-0866","volume":"59","author":"LC Stene","year":"2010","unstructured":"Stene, L. C. et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the diabetes and autoimmunity study in the young (DAISY). Diabetes 59, 3174\u20133180 (2010).","journal-title":"Diabetes"},{"key":"254_CR131","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00125-016-4177-z","volume":"60","author":"H Honkanen","year":"2017","unstructured":"Honkanen, H. et al. Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity. Diabetologia 60, 424\u2013431 (2017).","journal-title":"Diabetologia"},{"key":"254_CR132","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1974","volume":"28","author":"DW Allen","year":"2018","unstructured":"Allen, D. W., Kim, K. W., Rawlinson, W. D. & Craig, M. E. Maternal virus infections in pregnancy and type 1 diabetes in their offspring: systematic review and meta-analysis of observational studies. Rev. Med. Virol. 28, e1974 (2018).","journal-title":"Rev. Med. Virol."},{"key":"254_CR133","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrendo.2010.27","volume":"6","author":"D Hober","year":"2010","unstructured":"Hober, D. & Sauter, P. Pathogenesis of type 1 diabetes mellitus: interplay between enterovirus and host. Nature Rev. Endocrinol. 6, 279\u2013289 (2010).","journal-title":"Nature Rev. Endocrinol."},{"key":"254_CR134","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00125-002-0805-x","volume":"45","author":"M Roivainen","year":"2002","unstructured":"Roivainen, M. et al. Functional impairment and killing of human beta cells by enteroviruses: the capacity is shared by a wide range of serotypes, but the extent is a characteristic of individual virus strains. Diabetologia 45, 693\u2013702 (2002).","journal-title":"Diabetologia"},{"key":"254_CR135","doi-asserted-by":"crossref","first-page":"10423","DOI":"10.1128\/JVI.77.19.10423-10431.2003","volume":"77","author":"AN Lukashev","year":"2003","unstructured":"Lukashev, A. N. et al. Recombination in circulating enteroviruses. J. Virol. 77, 10423\u201310431 (2003).","journal-title":"J. Virol."},{"key":"254_CR136","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1099\/vir.0.81264-0","volume":"86","author":"AN Lukashev","year":"2005","unstructured":"Lukashev, A. N. et al. Recombination in circulating human enterovirus B: independent evolution of structural and non-structural genome regions. J. Gen. Virol. 86, 3281\u20133290 (2005).","journal-title":"J. Gen. Virol."},{"key":"254_CR137","first-page":"e01062","volume":"91","author":"SW Huang","year":"2017","unstructured":"Huang, S. W. et al. A selective bottleneck shapes the evolutionary mutant spectra of enterovirus A71 during viral dissemination in humans. J. Virol. 91, e01062\u201317 (2017).","journal-title":"J. Virol."},{"key":"254_CR138","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/jmv.10306","volume":"69","author":"T H\u00e4rk\u00f6nen","year":"2003","unstructured":"H\u00e4rk\u00f6nen, T. et al. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans. J. Med. Virol. 69, 426\u2013440 (2003).","journal-title":"J. Med. Virol."},{"key":"254_CR139","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.4049\/jimmunol.0900709","volume":"184","author":"MC Honeyman","year":"2010","unstructured":"Honeyman, M. C., Stone, N. L., Falk, B. A., Nepom, G. & Harrison, L. C. Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J. Immunol. 184, 2204\u20132210 (2010).","journal-title":"J. Immunol."},{"key":"254_CR140","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2337\/diabetes.49.8.1319","volume":"49","author":"MC Honeyman","year":"2000","unstructured":"Honeyman, M. C. et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49, 1319\u20131324 (2000).","journal-title":"Diabetes"},{"key":"254_CR141","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1046\/j.1365-2249.2002.01842.x","volume":"128","author":"M Blomqvist","year":"2002","unstructured":"Blomqvist, M. et al. Rotavirus infections and development of diabetes-associated autoantibodies during the first 2 years of life. Clin. Exp. Immunol. 128, 511\u2013515 (2002).","journal-title":"Clin. Exp. Immunol."},{"key":"254_CR142","first-page":"280","volume":"173","author":"KP Perrett","year":"2019","unstructured":"Perrett, K. P., Jachno, K., Nolan, T. M. & Harrison, L. C. Association of rotavirus vaccination with the incidence of type 1 diabetes in children. J. Am. Med. Assoc. Pediatr. 173, 280\u2013282 (2019).","journal-title":"J. Am. Med. Assoc. Pediatr."},{"key":"254_CR143","volume":"9","author":"MAM Rogers","year":"2019","unstructured":"Rogers, M. A. M., Basu, T. & Kim, C. Lower incidence rate of type 1 diabetes after receipt of the rotavirus vaccine in the United States, 2001-2017. Sci. Rep. 9, 7727 (2019).","journal-title":"Sci. Rep."},{"key":"254_CR144","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/INF.0000000000001600","volume":"36","author":"O Vaarala","year":"2017","unstructured":"Vaarala, O., Jokinen, J., Lahdenkari, M. & Leino, T. Rotavirus vaccination and the risk of celiac disease or type 1 diabetes in Finnish children at early life. Pediatr. Infect. Dis. J. 36, 674\u2013675 (2017).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"254_CR145","doi-asserted-by":"crossref","first-page":"5842701","DOI":"10.1155\/2016\/5842701","volume":"2016","author":"M Niegowska","year":"2016","unstructured":"Niegowska, M. et al. Recognition of ZnT8, proinsulin, and homologous MAP peptides in Sardinian children at risk of T1D precedes detection of classical islet antibodies. J. Diabetes Res. 2016, 5842701 (2016).","journal-title":"J. Diabetes Res."},{"key":"254_CR146","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/MOG.0b013e32830e6d98","volume":"24","author":"O Vaarala","year":"2008","unstructured":"Vaarala, O. Leaking gut in type 1 diabetes. Curr. Opin. Gastroenterol. 24, 701\u2013706 (2008).","journal-title":"Curr. Opin. Gastroenterol."},{"key":"254_CR147","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jaut.2006.04.003","volume":"27","author":"M M\u00e4kel\u00e4","year":"2006","unstructured":"M\u00e4kel\u00e4, M. et al. Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin. J. Autoimmun. 27, 54\u201361 (2006).","journal-title":"J. Autoimmun."},{"key":"254_CR148","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2337\/diacare.20.1.74","volume":"20","author":"T Ahmed","year":"1997","unstructured":"Ahmed, T. et al. Circulating antibodies to common food antigens in Japanese children with IDDM. Diabetes Care 20, 74\u201376 (1997).","journal-title":"Diabetes Care"},{"key":"254_CR149","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1203\/00006450-199109000-00019","volume":"30","author":"T Jalonen","year":"1991","unstructured":"Jalonen, T. et al. Increased beta-lactoglobulin absorption during rotavirus enteritis in infants: relationship to sugar permeability. Pediatr. Res. 30, 290\u2013293 (1991).","journal-title":"Pediatr. Res."},{"key":"254_CR150","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1007\/s00125-006-0465-3","volume":"49","author":"E Bosi","year":"2006","unstructured":"Bosi, E. et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 49, 2824\u20132827 (2006).","journal-title":"Diabetologia"},{"key":"254_CR151","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1399-5448.2008.00413.x","volume":"9","author":"K Luopaj\u00e4rvi","year":"2008","unstructured":"Luopaj\u00e4rvi, K. et al. Enhanced levels of cow's milk antibodies in infancy in children who develop type 1 diabetes later in childhood. Pediatr. Diabetes 9, 434\u2013441 (2008).","journal-title":"Pediatr. Diabetes"},{"key":"254_CR152","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/pedi.12788","volume":"20","author":"I Ekman","year":"2019","unstructured":"Ekman, I. et al. Early childhood CMV infection may decelerate the progression to clinical type 1 diabetes. Pediatr. Diabetes 20, 73\u201377 (2019).","journal-title":"Pediatr. Diabetes"},{"key":"254_CR153","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1111\/j.1749-6632.2009.04814.x","volume":"1173","author":"L Plot","year":"2009","unstructured":"Plot, L. et al. Infections may have a protective role in\u00a0the etiopathogenesis of celiac disease. Ann. N. Y. Acad. Sci. 1173, 670\u2013674 (2009).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"254_CR154","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/imm.12896","volume":"154","author":"Q Zhao","year":"2018","unstructured":"Zhao, Q. & Elson, C. O. Adaptive immune education by gut microbiota antigens. Immunology 154, 28\u201337 (2018).","journal-title":"Immunology"},{"key":"254_CR155","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nrendo.2015.218","volume":"12","author":"M Knip","year":"2016","unstructured":"Knip, M. & Siljander, H. The role of the intestinal microbiota in type 1 diabetes mellitus. Nature Rev. Endocrinol. 12, 154\u2013167 (2016).","journal-title":"Nature Rev. Endocrinol."},{"key":"254_CR156","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.cell.2016.05.056","volume":"165","author":"T Vatanen","year":"2016","unstructured":"Vatanen, T. et al. Variation in microbiome LPS immunogenicity contributes to autoimmunity in humans. Cell 165, 1551 (2016).","journal-title":"Cell"},{"key":"254_CR157","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/ismej.2010.92","volume":"5","author":"A Giongo","year":"2011","unstructured":"Giongo, A. et al. Toward defining the autoimmune microbiome for type 1 diabetes. ISME J. 5, 82\u201391 (2011).","journal-title":"ISME J."},{"key":"254_CR158","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2337\/db12-0526","volume":"62","author":"MC de Goffau","year":"2013","unstructured":"de Goffau, M. C. et al. Fecal microbiota composition differs between children with \u03b2-cell autoimmunity and those without. Diabetes 62, 1238\u20131244 (2013).","journal-title":"Diabetes"},{"key":"254_CR159","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3389\/fmicb.2014.00678","volume":"5","author":"AG Davis-Richardson","year":"2014","unstructured":"Davis-Richardson, A. G. et al. Bacteroides dorei dominates gut microbiome prior to autoimmunity in Finnish children at high risk for type 1 diabetes. Front.\u00a0Microbiol. 5, 678 (2014).","journal-title":"Front. Microbiol."},{"key":"254_CR160","volume":"6","author":"CT Brown","year":"2011","unstructured":"Brown, C. T. et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLOS ONE 6, e25792 (2011).","journal-title":"PLoS One"},{"key":"254_CR161","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1007\/s00125-015-3614-8","volume":"58","author":"AG Davis-Richardson","year":"2015","unstructured":"Davis-Richardson, A. G. & Triplett, E. W. A model for the role of gut bacteria in the development of autoimmunity for type 1 diabetes. Diabetologia 58, 1386\u20131393 (2015).","journal-title":"Diabetologia"},{"key":"254_CR162","first-page":"589","volume":"562","author":"T Vatanen","year":"2018","unstructured":"Vatanen, T. et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 562, 589\u2013594 (2018).","journal-title":"Naure"},{"key":"254_CR163","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-018-0617-x","volume":"562","author":"CJ Stewart","year":"2018","unstructured":"Stewart, C. J. et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 562, 583\u2013588 (2018).","journal-title":"Nature"},{"key":"254_CR164","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/pedi.12756","volume":"19","author":"R Insel","year":"2018","unstructured":"Insel, R. & Knip, M. Prospects for primary prevention of type 1 diabetes by restoring a disappearing microbe. Pediatr. Diabetes 19, 1400\u20131406 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"254_CR165","first-page":"20","volume":"170","author":"U Uusitalo","year":"2016","unstructured":"Uusitalo, U. et al. Association of early exposure of probiotics and islet autoimmunity in the TEDDY study. J. Am. Med. Assoc. Pediatr. 170, 20\u201328 (2016).","journal-title":"J. Am. Med. Assoc. Pediatr."},{"key":"254_CR166","doi-asserted-by":"crossref","first-page":"E6166","DOI":"10.1073\/pnas.1706359114","volume":"114","author":"G Zhao","year":"2017","unstructured":"Zhao, G. et al. Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children.\u00a0Proc. Natl Acad. Sci. USA 114, E6166\u2013E6175 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"254_CR167","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nri.2017.55","volume":"17","author":"ID Iliev","year":"2017","unstructured":"Iliev, I. D. & Leonardi, I. Fungal dysbiosis: immunity and interactions at mucosal barriers. Nat. Rev. Immunol. 17, 635\u2013646 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"254_CR168","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1210\/er.2017-00191","volume":"39","author":"KD Corbin","year":"2018","unstructured":"Corbin, K. D. et al. Obesity in type 1 diabetes: pathophysiology, clinical impact and mechanisms. Endocr. Rev. 39, 629\u2013663 (2018).","journal-title":"Endocr. Rev."},{"key":"254_CR169","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/ijo.2011.122","volume":"36","author":"A Carlsson","year":"2012","unstructured":"Carlsson, A. et al. Low risk HLA-DQ and increased body mass index in newly diagnosed type 1 diabetes children in the Better Diabetes Diagnosis study in Sweden. Int. J. Obes. 36, 718\u2013724 (2012).","journal-title":"Int. J. Obes. (Lond)"},{"key":"254_CR170","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11892-015-0628-z","volume":"15","author":"AM Nucci","year":"2015","unstructured":"Nucci, A. M., Virtanen, S. M. & Becker, D. J. Infant feeding and timing of complementary foods in the development of type 1 diabetes. Curr. Diab. Rep. 15, 62 (2015).","journal-title":"Curr. Diab. Rep."},{"key":"254_CR171","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00125-017-4280-9","volume":"60","author":"S Niinist\u00f6","year":"2017","unstructured":"Niinist\u00f6, S. et al. Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity. Diabetologia 60, 1223\u20131233 (2017).","journal-title":"Diabetologia"},{"key":"254_CR172","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.bbalip.2014.08.010","volume":"1851","author":"PC Calder","year":"2015","unstructured":"Calder, P. C. Marine omega-3 fatty acids and inflammatory processes: effects, mechanisms and clinical relevance. Biochim. Biophys. Acta 1851, 469\u2013484 (2015).","journal-title":"Biochim. Biophys. Acta"},{"key":"254_CR173","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00018-017-2672-0","volume":"75","author":"F Turroni","year":"2018","unstructured":"Turroni, F. et al. Bifidobacteria and the infant gut: an\u00a0example of co-evolution and natural selection. Cell\u00a0Mol. Life Sci. 75, 103\u2013118 (2018).","journal-title":"Cell Mol. Life Sci."},{"key":"254_CR174","doi-asserted-by":"crossref","first-page":"e194","DOI":"10.2337\/dc14-1208","volume":"37","author":"A Beyerlein","year":"2014","unstructured":"Beyerlein, A. et al. Timing of gluten introduction and islet autoimmunity in young children: updated results from the BABYDIET study. Diabetes Care 37, e194\u2013195 (2014).","journal-title":"Diabetes Care"},{"key":"254_CR175","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1001\/jama.290.13.1713","volume":"290","author":"JM Norris","year":"2003","unstructured":"Norris, J. M. et al. Timing of initial cereal exposure in infancy and risk of islet autoimmunity. J. Am. Med. Assoc. 290, 1713\u20131720 (2003).","journal-title":"J. Am. Med. Assoc."},{"key":"254_CR176","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/dc17-1983","volume":"41","author":"U Uusitalo","year":"2018","unstructured":"Uusitalo, U. et al. Early infant diet and islet autoimmunity in the TEDDY study. Diabetes Care 41, 522\u2013530 (2018).","journal-title":"Diabetes Care"},{"key":"254_CR177","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1093\/aje\/kwx191","volume":"187","author":"L Hakola","year":"2018","unstructured":"Hakola, L. et al. Infant feeding in relation to the risk of advanced islet autoimmunity and type 1 diabetes in children with increased genetic susceptibility: a cohort study. Am. J. Epidemiol. 187, 34\u201344 (2018).","journal-title":"Am. J. Epidemiol."},{"key":"254_CR178","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaut.2017.07.007","volume":"85","author":"F Colotta","year":"2017","unstructured":"Colotta, F., Jansson, B. & Bonelli, F. Modulation of inflammatory and immune responses by vitamin D. J.\u00a0Autoimmun. 85, 78\u201397 (2017).","journal-title":"J. Autoimmun."},{"key":"254_CR179","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s00125-006-0426-x","volume":"49","author":"B Littorin","year":"2006","unstructured":"Littorin, B. et al. Lower levels of plasma 25-hydroxyvitamin D among young adults at diagnosis of autoimmune type 1 diabetes compared with control subjects: results from the nationwide Diabetes Incidence Study in Sweden (DISS). Diabetologia 49, 2847\u20132852 (2006).","journal-title":"Diabetologia"},{"key":"254_CR180","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.3390\/nu5093551","volume":"5","author":"JY Dong","year":"2013","unstructured":"Dong, J. Y. et al. Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies. Nutrients 5, 3551\u20133562 (2013).","journal-title":"Nutrients"},{"key":"254_CR181","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1007\/s00125-011-2278-2","volume":"54","author":"M Simpson","year":"2011","unstructured":"Simpson, M. et al. No association of vitamin D intake or 25-hydroxyvitamin D levels in childhood with risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 54, 2779\u20132788 (2011).","journal-title":"Diabetologia"},{"key":"254_CR182","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1210\/jc.2015-3504","volume":"101","author":"M M\u00e4kinen","year":"2016","unstructured":"M\u00e4kinen, M. et al. Serum 25-hydroxyvitamin D concentrations in children progressing to autoimmunity and clinical type 1 diabetes. J. Clin. Endocrinol. Metab. 101, 723\u2013729 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"254_CR183","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2337\/db17-0802","volume":"67","author":"JM Norris","year":"2018","unstructured":"Norris, J. M. et al. Plasma 25-hydroxyvitamin D concentration and risk of islet autoimmunity. Diabetes 67, 146\u2013154 (2018).","journal-title":"Diabetes"},{"key":"254_CR184","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00125-008-0959-2","volume":"51","author":"L Uusitalo","year":"2008","unstructured":"Uusitalo, L. et al. Serum alpha- and gamma-tocopherol concentrations and risk of advanced beta cell autoimmunity in children with HLA-conferred susceptibility to type 1 diabetes mellitus. Diabetologia 51, 773\u2013780 (2008).","journal-title":"Diabetologia"},{"key":"254_CR185","doi-asserted-by":"crossref","first-page":"pii: E68","DOI":"10.3390\/nu10010068","volume":"10","author":"A Sanna","year":"2018","unstructured":"Sanna, A., Firinu, D., Zavattari, P. & Valera, P. Zinc status and autoimmunity: a systematic review and meta-analysis. Nutrients 10, E68 (2018).","journal-title":"Nutrients"},{"key":"254_CR186","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4239\/wjd.v7.i18.433","volume":"7","author":"Z Bahadoran","year":"2016","unstructured":"Bahadoran, Z., Ghasemi, A., Mirmiran, P., Azizi, F. & Hadaegh, F. Nitrate-nitrite-nitrosamines exposure and the risk of type 1 diabetes: a review of current data. World J. Diabetes 7, 433\u2013440 (2016).","journal-title":"World J. Diabetes"},{"key":"254_CR187","doi-asserted-by":"crossref","first-page":"M111.012203","DOI":"10.1074\/mcp.M111.012203","volume":"10","author":"W Zhi","year":"2011","unstructured":"Zhi, W. et al. Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays. Mol. Cell Proteom. 10, M111.012203 (2011).","journal-title":"Mol. Cell Proteom."},{"key":"254_CR188","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.20111843","volume":"210","author":"Q Zhang","year":"2013","unstructured":"Zhang, Q. et al. Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes. J.\u00a0Exp. Med. 210, 191\u2013203 (2013).","journal-title":"J. Exp. Med."},{"key":"254_CR189","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2337\/db14-0983","volume":"64","author":"R Moulder","year":"2015","unstructured":"Moulder, R. et al. Serum proteomes distinguish children developing type 1 diabetes in a cohort with HLA-conferred susceptibility. Diabetes 64, 2265\u20132278 (2015).","journal-title":"Diabetes"},{"key":"254_CR190","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00125-016-4150-x","volume":"60","author":"C von Toerne","year":"2017","unstructured":"von Toerne, C. et al. Peptide serum markers in islet autoantibody-positive children. Diabetologia 60, 287\u2013295 (2017).","journal-title":"Diabetologia"},{"key":"254_CR191","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.clinbiochem.2010.04.075","volume":"43","author":"CM Sorensen","year":"2010","unstructured":"Sorensen, C. M. et al. Perturbations in the lipid profile of individuals with newly diagnosed type 1 diabetes mellitus: lipidomics analysis of a diabetes antibody standardization program sample subset. Clin. Biochem. 43, 948\u2013956 (2010).","journal-title":"Clin. Biochem."},{"key":"254_CR192","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.2337\/db13-0159","volume":"62","author":"M Oresic","year":"2013","unstructured":"Oresic, M. et al. Cord serum lipidome in prediction of islet autoimmunity and type 1 diabetes. Diabetes 62, 3268\u20133274 (2013).","journal-title":"Diabetes"},{"key":"254_CR193","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1084\/jem.20081800","volume":"205","author":"M Oresic","year":"2008","unstructured":"Oresic, M. et al. Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes. J. Exp. Med. 205, 2975\u20132984 (2008).","journal-title":"J. Exp. Med."},{"key":"254_CR194","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.250","volume":"5","author":"S Lamichhane","year":"2018","unstructured":"Lamichhane, S. et al. A longitudinal plasma lipidomics dataset from children who developed islet autoimmunity and type 1 diabetes. Sci. Data 5, 180250 (2018).","journal-title":"Sci. Data"},{"key":"254_CR195","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1515\/hsz-2014-0282","volume":"396","author":"N Beyersdorf","year":"2015","unstructured":"Beyersdorf, N. & M\u00fcller, N. Sphingomyelin breakdown in T cells: role in activation, effector functions and immunoregulation. Biol. Chem. 396, 749\u2013758 (2015).","journal-title":"Biol. Chem."},{"key":"254_CR196","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00125-015-3752-z","volume":"59","author":"ML Campbell-Thompson","year":"2016","unstructured":"Campbell-Thompson, M. L. et al. The influence of type\u00a01 diabetes on pancreatic weight. Diabetologia 59, 217\u2013221 (2016).","journal-title":"Diabetologia"},{"key":"254_CR197","doi-asserted-by":"crossref","first-page":"E2109","DOI":"10.1210\/jc.2012-1815","volume":"97","author":"AJ Williams","year":"2012","unstructured":"Williams, A. J. et al. Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes. J. Clin. Endocrinol. Metab. 97, E2109\u2013E2113 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"254_CR198","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/dc18-1512","volume":"42","author":"ML Campbell-Thompson","year":"2019","unstructured":"Campbell-Thompson, M. L. et al. Relative pancreas volume is reduced in first-degree relatives of patients with type 1 diabetes. Diabetes Care 42, 281\u2013287 (2019).","journal-title":"Diabetes Care"},{"key":"254_CR199","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191528","volume":"13","author":"F Bonnet-Serrano","year":"2018","unstructured":"Bonnet-Serrano, F., Diedisheim, M., Mallone, R. & Larger, E. Decreased \u03b1-cell mass and early structural alterations of the exocrine pancreas in patients with type 1 diabetes: an analysis based on the nPOD repository. PLOS ONE 13, e0191528 (2018).","journal-title":"PLoS One"},{"key":"254_CR200","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-15-0674","volume":"174","author":"MK Koskinen","year":"2016","unstructured":"Koskinen, M. K. et al. Reduced \u03b2-cell function in early preclinical type 1 diabetes. Eur. J. Endocrinol. 174, 251\u2013259 (2016).","journal-title":"Eur. J. Endocrinol."},{"key":"254_CR201","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1210\/jc.2017-02040","volume":"103","author":"MK Koskinen","year":"2018","unstructured":"Koskinen, M. K. et al. Class II HLA genotype association with first-phase insulin response is explained by islet autoantibodies. J. Clin. Endocrinol. Metab. 103, 2870\u20132878 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"254_CR202","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.2337\/db13-0656","volume":"62","author":"JM Sosenko","year":"2013","unstructured":"Sosenko, J. M. et al. Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in diabetes prevention trial-type 1 participants. Diabetes 62, 4179\u20134183 (2013).","journal-title":"Diabetes"},{"key":"254_CR203","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00125-018-4712-1","volume":"61","author":"EK Sims","year":"2018","unstructured":"Sims, E. K., Evans-Molina, C., Tersey, S. A., Eizirik, D. L. & Mirmira, R. G. Biomarkers of islet beta cell stress and death in type 1 diabetes. Diabetologia 61, 2259\u20132265 (2018).","journal-title":"Diabetologia"},{"key":"254_CR204","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/pedi.12545","volume":"19","author":"J Ilonen","year":"2018","unstructured":"Ilonen, J. et al. Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity. Pediatr. Diabetes 19, 284\u2013292 (2018).","journal-title":"Pediatr. Diabetes"},{"key":"254_CR205","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.2337\/db14-0365","volume":"63","author":"S Arif","year":"2014","unstructured":"Arif, S. et al. Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes. Diabetes 63, 3835\u20133845 (2014).","journal-title":"Diabetes"},{"key":"254_CR206","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2337\/dc16-2228","volume":"40","author":"FK Gorus","year":"2017","unstructured":"Gorus, F. K. et al. Twenty-year progression rate to clinical onset according to autoantibody profile, age, and HLA-DQ genotype in a registry-based group of children and adults with a first-degree relative with type 1 diabetes. Diabetes Care 40, 1065\u20131072 (2017).","journal-title":"Diabetes Care"},{"key":"254_CR207","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/dme.13153","volume":"34","author":"S Arif","year":"2017","unstructured":"Arif, S. et al. \u03b2-cell specific T-lymphocyte response has a distinct inflammatory phenotype in children with type 1 diabetes compared with adults. Diabet Med. 34, 419\u2013425 (2017).","journal-title":"Diabet Med."},{"key":"254_CR208","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","volume":"58","author":"JP Krischer","year":"2015","unstructured":"Krischer, J. P. et al. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia 58, 980\u2013987 (2015).","journal-title":"Diabetologia"},{"key":"254_CR209","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1210\/jc.2017-00569","volume":"102","author":"E Bosi","year":"2017","unstructured":"Bosi, E. et al. Impact of age and antibody type on progression from single to multiple autoantibodies in type 1 diabetes relatives. J. Clin. Endocrinol. Metab. 102, 2881\u20132886 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"254_CR210","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11892-018-1066-5","volume":"18","author":"LM Jacobsen","year":"2018","unstructured":"Jacobsen, L. M. et al. Immune mechanisms and pathways targeted in type 1 diabetes. Curr. Diab. Rep. 18, 90 (2018).","journal-title":"Curr. Diab. Rep."},{"key":"254_CR211","first-page":"37","volume":"11","author":"J Dupr\u00e9","year":"1988","unstructured":"Dupr\u00e9, J. et al. Clinical trials of cyclosporin in IDDM. Diabetes Care 11 (Suppl. 1), 37\u201344 (1988).","journal-title":"Diabetes Care"},{"key":"254_CR212","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2017.19826","volume":"319","author":"M Knip","year":"2018","unstructured":"Knip, M. et al. Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes: the TRIGR randomized clinical trial. J. Am. Med. Assoc. 319, 38\u201348 (2018).","journal-title":"J. Am. Med. Assoc."},{"key":"254_CR213","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/gene.2012.36","volume":"13","author":"C Winkler","year":"2012","unstructured":"Winkler, C. et al. A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes. Genes Immun. 13, 549\u2013555 (2012).","journal-title":"Genes Immun."},{"key":"254_CR214","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/dc18-1785","volume":"42","author":"SA Sharp","year":"2019","unstructured":"Sharp, S. A. et al. Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis. Diabetes Care 42, 200\u2013207 (2019).","journal-title":"Diabetes Care"},{"key":"254_CR215","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2337\/dc18-0087","volume":"41","author":"MJ Redondo","year":"2018","unstructured":"Redondo, M. J. et al. A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk. Diabetes Care 41, 1887\u20131894 (2018).","journal-title":"Diabetes Care"},{"key":"254_CR216","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.2337\/db13-0094","volume":"62","author":"JA Noble","year":"2013","unstructured":"Noble, J. A., Johnson, J., Lane, J. A. & Valdes, A. M. HLA class II genotyping of African American type 1 diabetic patients reveals associations unique to African haplotypes. Diabetes 62, 3292\u20133299 (2013).","journal-title":"Diabetes"},{"key":"254_CR217","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1399-0039.1996.tb02512.x","volume":"47","author":"S Yasunaga","year":"1996","unstructured":"Yasunaga, S., Kimura, A., Hamaguchi, K., Ronningen, K. S. & Sasazuki, T. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM). Tissue Antigens 47, 37\u201348 (1996).","journal-title":"Tissue Antigens"},{"key":"254_CR218","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2337\/diabetes.51.2.545","volume":"51","author":"Y Kawabata","year":"2002","unstructured":"Kawabata, Y. et al. Asian-specific HLA haplotypes reveal heterogeneity of the contribution of HLA-DR and -DQ haplotypes to susceptibility to type 1 diabetes. Diabetes 51, 545\u2013551 (2002).","journal-title":"Diabetes"},{"key":"254_CR219","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/db09-0680","volume":"59","author":"MD Varney","year":"2010","unstructured":"Varney, M. D. et al. HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type\u00a01 diabetes: analysis of the type 1 diabetes genetics consortium families. Diabetes 59, 2055\u20132062 (2010).","journal-title":"Diabetes"},{"key":"254_CR220","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.2337\/db14-1497","volume":"64","author":"C T\u00f6rn","year":"2015","unstructured":"T\u00f6rn, C. et al. Role of type 1 diabetes-associated SNPs on risk of autoantibody positivity in the TEDDY study. Diabetes 64, 1818\u20131829 (2015).","journal-title":"Diabetes"},{"key":"254_CR221","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.2337\/db17-0261","volume":"66","author":"JP Krischer","year":"2017","unstructured":"Krischer, J. P. et al. The Influence of type 1 diabetes genetic susceptibility regions, age, sex, and family history on the progression from multiple autoantibodies to type 1 diabetes: a TEDDY study report. Diabetes 66, 3122\u20133129 (2017).","journal-title":"Diabetes"},{"key":"254_CR222","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.smim.2006.03.008","volume":"18","author":"N Bottini","year":"2006","unstructured":"Bottini, N., Vang, T., Cucca, F. & Mustelin, T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Semin. Immunol. 18, 207\u2013213 (2006).","journal-title":"Semin. Immunol."},{"key":"254_CR223","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.4049\/jimmunol.1100272","volume":"188","author":"G Garg","year":"2012","unstructured":"Garg, G. et al. Type 1 diabetes-associated IL2RA variation lowers IL-2 signaling and contributes to diminished CD4+CD25+ regulatory T cell function. J\u00a0Immunol 188, 4644\u20134653 (2012).","journal-title":"J. Immunol."},{"key":"254_CR224","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/gene.2015.51","volume":"17","author":"VM de Jong","year":"2016","unstructured":"de Jong, V. M. et al. Variation in the CTLA4 3' UTR has phenotypic consequences for autoreactive T cells and associates with genetic risk for type 1 diabetes. Genes Immun 17, 75\u201378 (2016).","journal-title":"Genes Immun."},{"key":"254_CR225","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2337\/db10-1269","volume":"60","author":"C Winkler","year":"2011","unstructured":"Winkler, C. et al. An interferon-induced helicase (IFIH1) gene polymorphism associates with different rates of progression from autoimmunity to type 1 diabetes. Diabetes 60, 685\u2013690 (2011).","journal-title":"Diabetes"},{"key":"254_CR226","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mce.2015.10.002","volume":"419","author":"S Kaur","year":"2016","unstructured":"Kaur, S. et al. The genetic and regulatory architecture of ERBB3-type 1 diabetes susceptibility locus. Mol. Cell Endocrinol. 419, 83\u201391 (2016).","journal-title":"Mol. Cell Endocrinol."},{"key":"254_CR227","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/bc95caf3-62cf-4ecd-8a79-9116e62f4a50","volume":"5","author":"H Wang","year":"2010","unstructured":"Wang, H. et al. Genetically dependent ERBB3 expression modulates antigen presenting cell function and type 1 diabetes risk. PLOS ONE 5, e11789 (2010).","journal-title":"PLoS One"},{"key":"254_CR228","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/dom.12162","volume":"15","author":"I Santin","year":"2013","unstructured":"Santin, I. & Eizirik, D. L. Candidate genes for type 1 diabetes modulate pancreatic islet inflammation and \u03b2-cell apoptosis. Diabetes Obes. Metab. 15, 71\u201381 (2013).","journal-title":"Diabetes Obes. Metab."},{"key":"254_CR229","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2016.09.004","volume":"76","author":"F Wiede","year":"2017","unstructured":"Wiede, F., Sacirbegovic, F., Leong, Y. A., Yu, D. & Tiganis, T. PTPN2-deficiency exacerbates T follicular helper cell and B cell responses and promotes the development of autoimmunity. J. Autoimmun. 76, 85\u2013100 (2017).","journal-title":"J. Autoimmun."},{"key":"254_CR230","doi-asserted-by":"crossref","first-page":"10305","DOI":"10.1073\/pnas.1402571111","volume":"111","author":"T Fl\u00f8yel","year":"2014","unstructured":"Fl\u00f8yel, T. et al. CTSH regulates \u03b2-cell function and disease progression in newly diagnosed type 1 diabetes patients. Proc. Natl Acad. Sci. USA 111, 10305\u201310310 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"254_CR231","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.2337\/db11-0638","volume":"60","author":"DJ Smyth","year":"2011","unstructured":"Smyth, D. J. et al. FUT2 nonsecretor status links type 1 diabetes susceptibility and resistance to infection. Diabetes 60, 3081\u20133084 (2011).","journal-title":"Diabetes"},{"key":"254_CR232","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.2337\/db13-1443","volume":"63","author":"L Marroqu\u00ed","year":"2014","unstructured":"Marroqu\u00ed, L. et al. BACH2, a candidate risk gene for type 1 diabetes, regulates apoptosis in pancreatic \u03b2-cells via JNK1 modulation and crosstalk with the candidate gene PTPN2. Diabetes 63, 2516\u20132527 (2014).","journal-title":"Diabetes"},{"key":"254_CR233","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00125-018-4561-y","volume":"61","author":"AB Sioofy-Khojine","year":"2018","unstructured":"Sioofy-Khojine, A. B. et al. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes. Diabetologia 61, 1193\u20131202 (2018).","journal-title":"Diabetologia"}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41574-019-0254-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-019-0254-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41574-019-0254-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T08:43:29Z","timestamp":1695199409000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-019-0254-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,18]]},"references-count":233,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1038\/s41574-019-0254-y","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,18]]},"assertion":[{"value":"13 August 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}